Siga Technologies INC Accounts Payable, Trade, Current
Siga Technologies INC (SIGA) had Accounts Payable, Trade, Current of $1.01 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableTradeCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Trade, Current $1.01M.
- 2026-03-31: Accounts Payable, Trade, Current $952.37K.
- 2025-12-31: Accounts Payable, Trade, Current $244.88K.
- 2025-09-30: Accounts Payable, Trade, Current $1.57M.
| Period end | Accounts Payable, Trade, Current |
|---|---|
| 2026-06-30 | $1.01M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $952.37K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $244.88K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.57M 10-Q · filed 2025-11-06 |
| 2025-03-31 | $9.26M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $105.28K 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.15M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $641.61K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $3.30M 10-K · filed 2025-03-11 |
| 2023-09-30 | $2.21M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $470.77K 10-Q · filed 2023-08-08 |
| 2022-12-31 | $31.16K 10-K · filed 2024-03-12 |
| 2022-09-30 | $380.41K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $477.88K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $130.07K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $488.08K 10-Q · filed 2022-11-03 |
| 2021-09-30 | $462.39K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $20.67K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $236.50K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $150.35K 10-K · filed 2022-03-03 |
| 2020-09-30 | $517.64K 10-Q · filed 2020-11-05 |
| 2019-12-31 | $71.54K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |